Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular gene therapy: current concepts

J C Fox1

  • 1Department of Medicine, University of Pennsylvania, Philadelphia, USA.

Therapeutic Drug Monitoring
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergency medicine (EM) can safely manage geriatric trauma patients sustaining ground level falls: Fostering EM autonomy while safely offloading a busy trauma service.

American journal of surgery·2022
Same author

Comparing Point-of-care-ultrasound (POCUS) to MRI for the Diagnosis of Medial Compartment Knee Injuries.

Journal of medical ultrasound·2018
Same author

The total synthesis of K-252c (staurosporinone) <i>via</i> a sequential C-H functionalisation strategy.

Chemical science·2017
Same author

Ultrasound in medical education: listening to the echoes of the past to shape a vision for the future.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2015
Same author

Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility.

Neurogastroenterology and motility·2014
Same author

Nystagmus.

The Yale journal of biology and medicine·2011
Same journal

Wide-Range Quantification of Belumosudil in Patients with Chronic Graft-Versus-Host Disease by High-Performance Liquid Chromatography.

Therapeutic drug monitoring·2026
Same journal

Deltamethrin Placental Transfer and Seasonal Pyrethroid Exposure: A Mother-Newborn Dyad Pilot Study.

Therapeutic drug monitoring·2026
Same journal

A Clustering-Based Grey Modeling Approach for Tacrolimus Concentration Prediction Under Sparse Therapeutic Drug Monitoring.

Therapeutic drug monitoring·2026
Same journal

Response to Panteghini "About Analytical Performance Specifications for Immunosuppressive Drug Measurements".

Therapeutic drug monitoring·2026
Same journal

Lacosamide Concentration in Various Biological Matrices (Plasma, Saliva, and Hair) Does Not Correlate with Clinical Outcomes in Patients with Epilepsy.

Therapeutic drug monitoring·2026
Same journal

Comparison of Creatinine-Based, Cystatin C-Based, and Combined Kidney Function Estimates for Vancomycin Clearance Prediction.

Therapeutic drug monitoring·2026
See all related articles

Gene therapy for cardiovascular disease requires identifying gene targets and suitable delivery vectors. This review covers strategies, vectors, and monitoring for clinical applications.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene therapy is a promising approach for cardiovascular diseases.
  • Understanding molecular pathophysiology is crucial for target identification.
  • Developing effective vectors and delivery systems remains a significant challenge.

Purpose of the Study:

  • To review gene therapy strategies for cardiovascular applications.
  • To provide an overview of available vectors and their use in cardiovascular gene transfer.
  • To discuss considerations for clinical application, including toxicity and monitoring.

Main Methods:

  • Literature review of gene therapy strategies.
  • Analysis of current vector technologies for cardiovascular gene transfer.

Related Experiment Videos

  • Discussion of toxicological and monitoring aspects of gene therapy.

    • Main Results:

    • Gene therapy development for cardiovascular disease is advancing.
    • Various vectors are available for cardiovascular gene transfer.
    • Toxicity and monitoring are key considerations for clinical translation.

    Conclusions:

    • Successful clinical application of cardiovascular gene therapy depends on strategic target selection and vector development.
    • Broader concepts of toxicology and therapeutic drug monitoring are essential for gene therapeutic agents.
    • Guidelines for clinical monitoring can be informed by vector-specific toxicities and genetic modification types.